Evidence map›Paper›PMID 36463856›Full record

ReviewOncology research and treatment2023

Perspectives for Cancer Care and Research in Central and Eastern Europe.

Christoph C Zielinski, Tanja Cufer, Bostjan Seruga, Jacek Jassem, Mircea Dediu, Christiane Thallinger

Open access · hybridAbstract readReview
In one paragraph

Review in Oncology research and treatment, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Christoph C ZielinskiWiener Privatklinik, Central European Academy Cancer Center, Vienna, Austria.
Tanja CuferMedical Faculty, University of Ljubljana, Slovenia, Ljubljana, Slovenia.
Bostjan SerugaMedical Oncology Department, SANADOR Oncology Center, Bucharest, Romania.
Jacek JassemDepartment of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.
Mircea DediuDivision of Medical Oncology, Institute of Oncology Ljubljana and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Christiane ThallingerCentral European Cooperative Oncology Group, Vienna, Austria.
Central European Cooperative Oncology Group · ATGdańsk Medical University · PLInstitute of Oncology Ljubljana · SIMedical University of Vienna · ATUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiscrepancies between the outcomes of cancer patients between Western European and Central and Eastern European (CEE) countries have often been observed. Despite the enormous economic and civilizational progress made in these countries after the abolishment of the communist regime, structural problems persist. SUMMARY: The present article reviews the domains of medical oncology education, human resources in oncology, cancer care, and clinical research in CEE in order to comprehensively assess the current situation and needs, describe important initiatives, and also propose ways to improving cancer outcomes in the region. Activities are under way to address these issues in national action plans to divert funding into oncology-related education, research, the purchase of equipment, and the attainment of modern hospital organization and structures. KEY MESSAGE: Over the past more than 30 years, CEE countries have made enormous economic and societal progress. Nevertheless, challenges especially in the health care sector persist.

Indexed as

NeoplasmsEducational StatusEuropeEurope, EasternHumansMedical OncologyCancer careCentral and Eastern EuropeClinical researchEducationHuman resourcesOncology

Identifiers

PMID36463856
PMCPMC10015746
OpenAlexW4310704944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.